戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HCID 4742004作成日:2026年10月26日

1-シクロプロピルピペラジン

1-シクロプロピルピペラジン · Cyclopropyl piperazine · N-cyclopropylpiperazine · 1-Cyclopropylpiperazine · Piperazine,1-cyclopropyl- · 1-Cyclopropylpiperazine >(Piperazin-1-yl)cyclopropane · 1-(Cyclopropyl Phenyl)Piperazine · 1-Cyclopropylpiperazine - [C14363]

https://huagongshe.com/ja/chemical/4742004

1-シクロプロピルピペラジン の分子構造式

識別子と物理属性

CAS No.20327-23-5
分子式C7H14N2
平均分子量126.2 g/mol
単同位体質量126.11569845 g/mol
SMILESC1CN(C2CC2)CCN1
InChIKeyHNZJIWIXRPBFAN-UHFFFAOYSA-N
PubChem CID4742004
EC No.807-993-7
DTXSIDDTXSID20406303
現地名1-シクロプロピルピペラジン

化学・物理的性質

XLogP0.2
極性表面積15.3
水素結合供与体数1
水素結合受容体数2
回転可能結合数1
重原子数9
形式電荷0
複雑度93.1
沸点43°C/7mm
密度0.94
屈折率1.4804
貯蔵条件Keep in dark place,Sealed in dry,Room Temperature
外観・状態clear liquid
pKa(酸解離定数)9.23±0.10(Predicted)
色Colorless to Light yellow
InChIInChI=1S/C7H14N2/c1-2-7(1)9-5-3-8-4-6-9/h7-8H,1-6H2
InChIKeyHNZJIWIXRPBFAN-UHFFFAOYSA-N
SMILESN1(C2CC2)CCNCC1

安全性と法規制

GHS 分類DangerH302 (60%): Harmful if swallowed [Warning Acute toxicity, oral]P260, P261, P264, P264+P265, P270, P271, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P351+P338, P305+P354+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P363, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 5 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and CategoriesAcute Tox. 4 (60%)
輸送番号(UN)3267
税関コード2933599590
消防法危-4-3-III
危険表示Xi
危険等級8
包装等級Ⅲ

用途

使用

1-cyclopropylpiperazine is a piperazine derivative known in the literature by synonyms such as N-cyclopropylpiperazine and 4-cyclopropylpiperazine. It has been used in the preparation of some tri- and tetrasubstituted ureas with histamine H3 antagonist receptor activity, 3-amido-4- anilinoquinolines series as CSF-1R kinase inhibitors, for the synthesis of cyclopropyl amines as modulators of the histamine H3 receptor, sulfonamide compounds as cysteine protease inhibitors, N-oxides as antibacterial agents and in the treatment of the disease caused by helicobacter infection[1].